Gastroesophageal Reflux Disease Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Gastroesophageal Reflux Disease Market size is expected to grow at an annual average of 2% during 2022-2028. Gastroesophageal reflux disease, also known as GERD, is a digestive disorder that affects the muscular ring between the esophagus and stomach. The lower esophageal sphincter is the name given to this ring (LES). A person may suffer from heartburn or acid indigestion. Doctors think that some people develop it as a result of a disorder known as hiatus hernia. In most cases, GERD symptoms can be relieved with diet and lifestyle adjustments.

The following segmentation are covered in this report:

By Drug Type

• Proton Pump Inhibitors (PPIs)
• H2 Receptor Blockers
• Others

By Product

• Diagnosis
• Upper Endoscopy
• Ambulatory Acid (pH) Probe Test
• Esophageal Manometry
• Others

Company Profile

• GlaxoSmithKline PLC
• SRS Life Sciences
• Johnson & Johnson
• Medtronic Plc
• Pfizer, Inc.
• Reckitt Benckiser Group Plc
• Takeda Pharmaceutical Co., Ltd.
• Teva Pharmaceuticals Industries Limited.

Scope of the report

The research study analyses the Gastroesophageal Reflux Disease Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Gastroesophageal Reflux Disease Market Report

• What was the Gastroesophageal Reflux Disease Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Gastroesophageal Reflux Disease Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.